As of 2024-09-14, the Relative Valuation of Abbott Laboratories (ABT) is 132.01 USD. This relative valuation is based on P/E multiples. With the latest stock price at 116.40 USD, the upside of Abbott Laboratories based on Relative Valuation is 13.4%.
The range of the Relative Valuation is 122.08 - 140.27 USD.
| Range | Selected | |
| Trailing P/E multiples | 39.1x - 43.9x | 41.3x |
| Forward P/E multiples | 31.6x - 36.3x | 34.2x |
| Fair Price | 122.08 - 140.27 | 132.01 |
| Upside | 4.9% - 20.5% | 13.4% |
| Date | P/E |
| 2024-09-13 | 36.44 |
| 2024-09-12 | 36.58 |
| 2024-09-11 | 36.51 |
| 2024-09-10 | 36.67 |
| 2024-09-09 | 36.45 |
| 2024-09-06 | 35.65 |
| 2024-09-05 | 35.41 |
| 2024-09-04 | 35.82 |
| 2024-09-03 | 35.90 |
| 2024-08-30 | 35.46 |
| 2024-08-29 | 35.31 |
| 2024-08-28 | 35.35 |
| 2024-08-27 | 35.41 |
| 2024-08-26 | 35.29 |
| 2024-08-23 | 35.28 |
| 2024-08-22 | 35.10 |
| 2024-08-21 | 34.88 |
| 2024-08-20 | 34.68 |
| 2024-08-19 | 35.04 |
| 2024-08-16 | 34.75 |
| 2024-08-15 | 34.74 |
| 2024-08-14 | 34.41 |
| 2024-08-13 | 33.89 |
| 2024-08-12 | 33.75 |
| 2024-08-09 | 34.04 |
| 2024-08-08 | 34.37 |
| 2024-08-07 | 34.42 |
| 2024-08-06 | 34.28 |
| 2024-08-05 | 34.01 |
| 2024-08-02 | 34.85 |
| 2024-08-01 | 34.49 |
| 2024-07-31 | 33.17 |
| 2024-07-30 | 32.98 |
| 2024-07-29 | 32.80 |
| 2024-07-26 | 32.95 |
| 2024-07-25 | 33.18 |
| 2024-07-24 | 33.58 |
| 2024-07-23 | 32.54 |
| 2024-07-22 | 32.47 |
| 2024-07-19 | 31.95 |
| 2024-07-18 | 31.33 |
| 2024-07-17 | 32.78 |
| 2024-07-16 | 32.16 |
| 2024-07-15 | 32.24 |
| 2024-07-12 | 32.63 |
| 2024-07-11 | 32.62 |
| 2024-07-10 | 32.27 |
| 2024-07-09 | 31.82 |
| 2024-07-08 | 31.97 |
| 2024-07-05 | 32.57 |